Epigenetic g predicts cognitive aging and incident dementia in a diverse, nationally representative sample of older adults
Preprint
Abstract
Background: Alzheimer’s disease and related dementias (ADRD) are major public health concerns. DNA methylation (DNAm)–based biomarkers such as GrimAge and PhenoAge predict aging and health risk, but were not designed to optimize prediction of cognitive decline. Epigenetic g —a DNAm-derived index of general cognitive ability—is a promising marker of cognitive function that has not been assessed in a racially and socioeconomically diverse population. Methods: We used data from the 2016 Venous Blood Study of the Health and Retirement Study (HRS), a nationally representative cohort of U.S. adults aged ≥51 years (N = 3575 with high-quality DNAm). Epigenetic g scores were computed using CpG weights from a BayesR+ model of general cognitive ability developed in Generation Scotland. Cognitive function was measured with a modified version of the Telephone Interview for Cognitive Status (TICS) at each interview wave; 6-year incident dementia was defined using the validated Langa–Weir algorithm. Linear regression estimated associations with cognitive scores; logistic regression estimated 4-year dementia risk. Models were adjusted sequentially for demographics, education, parental education, APOE ε4 status, and blood-based neurodegeneration markers (NfL, GFAP, Aβ42/40, pTau181). Results: Higher epigenetic g was associated with better baseline cognition (β=2.55, 95% CI 1.92–3.17) and cognition at the time DNAm was measured (β=2.30, 95% CI 1.62–2.99) after demographic adjustment. Associations attenuated but remained significant with education and parental education (β=1.23–1.89). Each unit increase in epigenetic g predicted 29% lower 6-year risk of dementia (fully adjusted HR=0.71). Results were robust to adjustment for APOE ε4 and neurodegeneration biomarkers. Conclusions: Epigenetic g is a scalable, blood-based marker of cognitive function and dementia risk that adds predictive value beyond demographics, socioeconomic indicators, APOE, and neuropathology. Its validation in a diverse, nationally representative U.S. cohort underscores its potential for early risk profiling and for research on social determinants of cognitive aging in cross-national samples.Keywords
This publication has 25 references indexed in Scilit:
- Epigenetic-based age acceleration in a representative sample of older Americans: Associations with aging-related morbidity and mortalityProceedings of the National Academy of Sciences, 2023
- The Socioeconomic Gradient in Epigenetic Ageing Clocks: Evidence from the Multi-Ethnic Study of Atherosclerosis and the Health and Retirement StudyEpigenetics, 2021
- Resource profile and user guide of the Polygenic Index RepositoryNature Human Behaviour, 2021
- Structural brain correlates of serum and epigenetic markers of inflammation in major depressive disorderBrain, Behavior, and Immunity, 2021
- Associations of Age, Sex, Race/Ethnicity, and Education With 13 Epigenetic Clocks in a Nationally Representative U.S. Sample: The Health and Retirement StudyThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2021
- Analysis of dementia in the US population using Medicare claims: Insights from linked survey and administrative claims dataAlzheimer's & Dementia: Translational Research & Clinical Interventions, 2019
- Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive functionNature Communications, 2018
- A Comparison of the Prevalence of Dementia in the United States in 2000 and 2012JAMA Internal Medicine, 2017
- Genome-wide association study identifies 74 loci associated with educational attainmentNature, 2016
- Assessment of Cognition Using Surveys and Neuropsychological Assessment: The Health and Retirement Study and the Aging, Demographics, and Memory StudyThe Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 2011